New concepts in the treatment of uterine leiomyomas

Obstetrics and Gynecology

Volumn 92, Issue 4, 1998, Pages 624-627

  Stewart, Elizabeth A ^a   Nowak, Romana A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIGESTAGEN; DNA; ESTROGEN; FIBROBLAST GROWTH FACTOR; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; PIRFENIDONE; PROGESTERONE; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; CARCINOGENESIS; CELL PROLIFERATION; DIET THERAPY; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; UTERUS MYOMA;

FEMALE; GROWTH SUBSTANCES; HUMANS; LEIOMYOMA; UTERINE NEOPLASMS;

EID: 0031689026     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/s0029-7844(98)00243-9     Document Type: Article

References (15)

1. Kelly HA. Operative gynecology. 2nd ed. New York: D. Appleton, 1906.
2. Stewart EA, Nowak RA. Leiomyoma-related bleeding: A classic hypothesis updated for the molecular era. Hum Reprod Update 1996;2:295-306.
3. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, et al. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A 1987;84:2292-6.
4. Mangrulkar RS, Ono M, Ishikawa M, Takashima S, Klagsbrun M, Nowak RA. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biol Reprod 1995;53:636-46.
5. Anania CA, Stewart EA, Quade BJ, Hill JA, Nowak RA. Expression of the fibroblast growth factor receptor in women with and without leiomyomas and abnormal uterine bleeding. Molec Hum Reprod 1997;3:685-91.
6. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Shultz GS, et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 1996; 81:3222-30.
7. Lindner V, Reidy MR. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against fibroblast growth factor. Proc Natl Acad Sci U S A 1991;88:3739-43.
8. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A 1995;92:6911-4.
9. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
10. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, et al. Past infection by Chlamydia pneumoniae train TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med 1993;95:499- 504.
11. Schoenberg Fejzo M, Ashar HR, Krauter KS, Powell WL, Rein MS, Weremowicz S, et al. Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosomes Cancer 1996;17:1-6.
12. Williams AJ, Powell WL, Collins T, Morton CC. HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am J Pathol 1997;150:911-8.
13. Mashal RD, Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 1994;11:1-6.
14. Lee BS, Stewart EA, Sahakian M, Nowak RA. Interferon-a is a potent inhibitor of basic fibroblast growth factor-stimulated cell proliferation in human uterine cells. Am J Repro Immunol 1998; 40:19-25.
15. Lee BS, Margolin SB, Nowak RA. Pirfenidone: A novel pharmacologic agent that inhibits leiomyoma cell proliferation and collagen production. J Clin Endocrinol Metab 1998;83:219-23.